(2022). Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Saf. http://doi.org/10.1007/s40264-022-01263-3
. C. Johannes
First name
C.
Middle name
B.
Last name
Johannes
(2022). Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Saf. http://doi.org/10.1007/s40264-022-01262-4
. (2015). Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study. Drug Saf. http://doi.org/10.1007/s40264-015-0338-0
. (2016). Improving the Identification of Out-of-Hospital Sudden Cardiac Deaths in a General Practice Research Database. Drugs Real World Outcomes. http://doi.org/10.1007/s40801-016-0086-1
.